AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME

AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME was reported 59 times

These drug classes are most commonly taken by patients reporting AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME:

# Drug Count
0 Corticosteroid [EPC] 31
1 CD20-directed Cytolytic Antibody [EPC] 28
2 Alkylating Drug [EPC] 23
3 Nucleoside Metabolic Inhibitor [EPC] 19
4 Folate Analog Metabolic Inhibitor [EPC] 7
5 Tumor Necrosis Factor Blocker [EPC] 5
6 Calcineurin Inhibitor Immunosuppressant [EPC] 4
7 Human Immunoglobulin G [EPC] 3
8 Provitamin D2 Compound [EPC] 3
9 Alkaloid [EPC] 2
10 Catecholamine [EPC] 2
11 Fluoroquinolone Antibacterial [EPC] 2
12 Human C1 Esterase Inhibitor [EPC] 2
13 Kinase Inhibitor [EPC] 2
14 Osmotic Laxative [EPC] 2
15 Serotonin-3 Receptor Antagonist [EPC] 2
16 alpha-Adrenergic Agonist [EPC] 2
17 beta-Adrenergic Agonist [EPC] 2
18 mTOR Inhibitor Immunosuppressant [EPC] 2
19 Aluminum Complex [EPC] 1
20 Bile Acid Sequestrant [EPC] 1
21 Bile Acid [EPC] 1
22 CD19-directed Chimeric Antigen Receptor [EPC] 1
23 CD30-directed Immunoconjugate [EPC] 1
24 Epidermal Growth Factor Receptor Antagonist [EPC] 1
25 Factor Xa Inhibitor [EPC] 1
26 Genetically-modified Autologous T Cells [EPC] 1
27 HER2/neu Receptor Antagonist [EPC] 1
28 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
29 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
30 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
31 Immunoglobulin G [EPC] 1
32 Interleukin-1 Receptor Antagonist [EPC] 1
33 Interleukin-17A Antagonist [EPC] 1
34 Muscle Relaxant [EPC] 1
35 Plasma Kallikrein Inhibitor [EPC] 1
36 Platinum-based Drug [EPC] 1
37 Proton Pump Inhibitor [EPC] 1
38 Selective T Cell Costimulation Modulator [EPC] 1
39 Thrombopoietin Receptor Agonist [EPC] 1
40 Topoisomerase Inhibitor [EPC] 1
41 Vascular Endothelial Growth Factor Inhibitor [EPC] 1